Skip to Content

Enviracor J-5

This page contains information on Enviracor J-5 for veterinary use.
The information provided typically includes the following:
  • Enviracor J-5 Indications
  • Warnings and cautions for Enviracor J-5
  • Direction and dosage information for Enviracor J-5

Enviracor J-5

This treatment applies to the following species:
Manufacturer: Zoetis

Escherichia Coli Bacterin

Enviracor J5 is recommended for use in healthy dairy cattle as an aid in the control of clinical signs associated with E. coli mastitis. For effective mastitis control this product should be used in conjunction with acceptable good management practices.

Directions For Use

Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.

Precautions

Store at 35°-45°F (2°-7°C). Do not freeze. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. In case of anaphylactoid reactions, epinephrine should be administered immediately.

Mfd by: Poultry Health Laboratories (A Division of PHL Associates, Inc.), Davis, CA 95616

US Veterinary License No. 357

Dist by: Zoetis Inc., Kalamazoo, MI 49007

 

NDC

 

100 mL (20 doses)

0009-3637-05

12980900

250 mL (50 doses)

0009-3637-06

12981000

NAC No.: 36903482

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-359-4414
Customer Service:   888-963-8471
Website:   www.zoetis.com
Every effort has been made to ensure the accuracy of the Enviracor J-5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide